News
16m
InvestorsHub on MSNQualigen Therapeutics shares surge after patent approvals in 25 countriesQualigen Therapeutics (NASDAQ:QLGN) saw its stock jump 80% following news that it secured new patents spanning 25 countries for its cancer drug QN-302. The patents, titled “Substituted Naphthalene ...
The life expectancy has increased in the U.S. and worldwide, contributing to healthcare companies retaining their patients ...
Additionally, Nitto exits production of materials in decline, or for which it no longer has a competitive advantage. For instance, in 2020 it ceased manufacturing liquid crystal display materials, ...
Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...
WHOWHATWHEREWHENWHYNuwellis, Inc.Issuance of U.S. Patent No. 12,357,734United States Patent and Trademark OfficeJuly 15, 2025To protect innovations in blood filtering system design and methods that ...
PRNewswire/ -- trū® Chitosan, a brand of iterro Life Sciences, announced the introduction of trū Chitosan USP Inhalant—the ...
Think patents are just legal jargon or a guaranteed payday? Discover the surprising truths behind common U.S. patent myths and what you really need to know before you file.
Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...
Patent Bots, creator of AI-enabled software for patent attorneys, today announced the launch of its newest product, ...
Decades of experience in higher education and research in India, expressing concerns and advocating for quality and ...
On Monday, the Federal Circuit issued a precedential decision dismissing cardiovascular health company Shockwave Medical’s ...
Efforts to extend the patent globally are already underway LOS ANGELES, July 15, 2025 /PRNewswire/ -- Today, Voodoo Scientific, the innovators behind the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results